The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Anne Elizabeth Samuel - JP Morgan Chase & Co, Research Division - Analyst
: I was hoping you could maybe speak to what you're seeing in the software business around selling. Are decisions still being made? Are you having
to sell differently in this environment? What's going on there?
without the prior written consent of Thomson Reuters. 'Thomson Reuters' and the Thomson Reuters logo are registered trademarks of Thomson Reuters and its
affiliated companies.
APRIL 23, 2020 / 12:30PM, PHR.N - Q4 2020 Phreesia Inc Earnings Call
Question: Anne Elizabeth Samuel - JP Morgan Chase & Co, Research Division - Analyst
: That's really helpful. And then maybe -- obviously, it's really difficult at this point to predict what the recovery is going to look like. But are you
expecting to see some pent-up demand within your practices once they start reopening and maybe expect to see it kind of on a rolling regional
basis? And how are your providers preparing for that pent-up demand if they're expecting it?
Question: Anne Elizabeth Samuel - JP Morgan Chase & Co, Research Division - Analyst
: Sure. Yes, I mean it's really just...
Question: Anne Elizabeth Samuel - JP Morgan Chase & Co, Research Division - Analyst
: Are you expecting pent-up demand from procedures that are being deferred? And how are your providers preparing to address that?
Question: Anne Elizabeth Samuel - JP Morgan Chase & Co, Research Division - Analyst
: You did.
Question: Sean Wilfred Dodge - RBC Capital Markets, Research Division - Analyst
: Maybe going back to the implementations for a moment. Chaim, you mentioned with Memorial being able to accelerate the rollout there using
more virtual processes, what was it about Memorial that allowed you to accelerate there and not others? Is it just up to the -- is it the willingness
and resources of the specific clients? Or is there something else mechanically or, I don't know, physically constraining other sites or other practices
to kind of continue their rollouts over the course of this?
Question: Sean Wilfred Dodge - RBC Capital Markets, Research Division - Analyst
: Okay. That's helpful. And then on the hardware, the pads and kiosks you put into the clinics, your supply chains for all that, I'd imagine, at least
some of the components that go into it are sourced from some of the geographies affected by all this. Are -- has there been any disruption in supply
chain? How much inventory you have on hand? Is there any reason to be concerned there at all?
without the prior written consent of Thomson Reuters. 'Thomson Reuters' and the Thomson Reuters logo are registered trademarks of Thomson Reuters and its
affiliated companies.
APRIL 23, 2020 / 12:30PM, PHR.N - Q4 2020 Phreesia Inc Earnings Call
| 
